Evidence map›Paper›PMID 38844208›Full record

ArticleMucosal immunology2024

Metabolically active neutrophils represent a permissive niche for Mycobacterium tuberculosis.

J Tucker Andrews, Zijing Zhang, G V R Krishna Prasad, Fischer Huey, Evgeniya V Nazarova, Jocelyn Wang, Ananya Ranaraja, Tiffany Weinkopff, Lin-Xi Li, Shengyu Mu and 7 more

Abstract read
In one paragraph

Article in Mucosal immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

J Tucker AndrewsDepartment of Microbiology and Immunology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Zijing ZhangDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
G V R Krishna PrasadDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Fischer HueyDepartment of Microbiology and Immunology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Evgeniya V NazarovaDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Jocelyn WangDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Ananya RanarajaDepartment of Microbiology and Immunology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Tiffany WeinkopffDepartment of Microbiology and Immunology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Lin-Xi LiDepartment of Microbiology and Immunology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Shengyu MuDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Michael J BirrerDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Stanley Ching-Cheng HuangPelotonia Institute for Immuno-Oncology, The Ohio State University College of Medicine, Columbus, OH, USA; Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, OH, USA.
Nan ZhangImmunology, Metastasis & Microenvironment Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA.
Rafael J ArgüelloAix-Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Jennifer A PhilipsDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA; Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
Joshua T MattilaDepartment of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Lu HuangDepartment of Microbiology and Immunology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: lhuang@uams.edu.

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Study of the Cell-specific Inflammasome Responses During Defense Against Gram-negative BacteriaP20GM103625 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2012 to 2021
$21.5M
Pilot Grant ProgramP30GM145393 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI MARK S SMELTZER · 2022 to 2026
$7.6M
Mechanisms of Innate Immune Evasion by Mycobacterium TuberculosisR01AI130454 · NIAID · WASHINGTON UNIVERSITY · PI JENNIFER A PHILIPS · 2017 to 2026
$5.9M
T cell homing to the kidney contributes to salt retention and blood pressure regulationR01HL146713 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI Shengyu Mu · 2019 to 2026
$4.2M
A mechanistic understanding of tuberculosis progression through bacterial reporter strainsR01AI134183 · NIAID · CORNELL UNIVERSITY · PI RUSSELL, DAVID G · 2017 to 2021
$3.5M
PET Probes Targeting Immune Cells for Imaging TuberculosisR01AI118195 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FLYNN, JOANNE L. · 2015 to 2019
$3.5M
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TBR01AI164970 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bryan David Bryson, Joshua T. Mattila · 2022 to 2026
$2.7M
UC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5M
Mechanisms of memory CD4 T cell-mediated immune protection against ChlamydiaR01AI139124 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI LI, LIN-XI · 2018 to 2022
$1.9M
Macrophage metabolism in diabetes and tuberculosis comorbidityR21AI175738 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI HUANG, LU · 2023 to 2024
$438k
The Role of SLAMF1 in TB ImmunityR21AI155380 · NIAID · WASHINGTON UNIVERSITY · PI PHILIPS, JENNIFER A · 2020 to 2021
$433k
NCI NIH HHS P30 CA010815NHLBI NIH HHS R01 HL146713NIAID NIH HHS R01 AI118195NIAID NIH HHS R01 AI130454NIAID NIH HHS R01 AI134183NIAID NIH HHS R01 AI139124NIAID NIH HHS R01 AI164970NIAID NIH HHS R21 AI155380NIAID NIH HHS R21 AI175738NIAID NIH HHS R25 AI147376NIGMS NIH HHS P20 GM103625NIGMS NIH HHS P30 GM145393
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb)-infected neutrophils are often found in the airways of patients with active tuberculosis (TB), and excessive recruitment of neutrophils to the lung is linked to increased bacterial burden and aggravated pathology in TB. The basis for the permissiveness of neutrophils for Mtb and the ability to be pathogenic in TB has been elusive. Here, we identified metabolic and functional features of neutrophils that contribute to their permissiveness in Mtb infection. Using single-cell metabolic and transcriptional analyses, we found that neutrophils in the Mtb-infected lung displayed elevated mitochondrial metabolism, which was largely attributed to the induction of activated neutrophils with enhanced metabolic activities. The activated neutrophil subpopulation was also identified in the lung granulomas from Mtb-infected non-human primates. Functionally, activated neutrophils harbored more viable bacteria and displayed enhanced lipid uptake and accumulation. Surprisingly, we found that interferon-γ promoted the activation of lung neutrophils during Mtb infection. Lastly, perturbation of lipid uptake pathways selectively compromised Mtb survival in activated neutrophils. These findings suggest that neutrophil heterogeneity and metabolic diversity are key to their permissiveness for Mtb and that metabolic pathways in neutrophils represent potential host-directed therapeutics in TB.

Indexed as

Mycobacterium tuberculosisNeutrophil ActivationNeutrophilsAnimalsDisease Models, AnimalHost-Pathogen InteractionsHumansInterferon-gammaLungMiceMitochondriaTuberculosisTuberculosis, PulmonaryInterferon-gamma

Identifiers

PMID38844208
PMCPMC11493682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.